ArticleBMC neurology2026
A dual manifestation of GAD-antibody spectrum disorder: a case of progressive encephalomyelitis with rigidity, myoclonus and autoimmune epilepsy with mesial temporal sclerosis.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Stiff Person Syndrome: Bridging Neuroimmunology and Rehabilitation for Improved Patient Outcomes.Archives of internal medicine research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProgressive encephalomyelitis with rigidity and myoclonus (PERM) is a rare neurological disorder within the spectrum of stiff-person syndrome (SPS) and epilepsy, and is part of the group of GAD (glutamic acid decarboxylase) antibody-associated disorders. PERM diagnosis is often challenging due to its heterogeneous presentation, and treatment remains difficult, as clear therapeutic guidelines for this condition have yet to be established. To the best of our knowledge, no prior reports have documented the simultaneous occurrence of PERM and anti-GAD–positive autoimmune epilepsy associated with mesial temporal sclerosis (MTS), thus highlighting a previously unrecognised phenotype within the GAD-spectrum disorders. CASE REPORT: We present the case of a 32-year-old male with a progressive neurological syndrome characterised by lower limb rigidity, gait disturbance, painful spasms, and hyperekplexia. Over five years, he developed epileptic seizures, stimulus-induced myoclonus, and neuropsychiatric symptoms (emotional lability, depressive affect, anxiety). High titers of anti-GAD antibodies in serum, along with EMG findings, supported the diagnosis of PERM. Brain MRI revealed right MTS. Symptomatic treatment with GABAergic agents led to significant clinical improvement; immunotherapy was considered but not initially required due to the positive response.
conclusionsThis case represents, to the best of our knowledge, the first reported instance of PERM coexisting with anti-GAD–positive autoimmune epilepsy and MTS, underscoring the clinical relevance of recognizing overlapping GAD-spectrum phenotypes to guide timely diagnosis and individualized management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.